The Labor Law Insider: NLRB Does a U-Turn on Make-Whole Settlement Remedies, Part II
Cruising Through Change: The Auto-Finance Industry’s New Era Under Trump Unveiled — The Consumer Finance Podcast
False Claims Act Insights - Will Recent Leadership Changes Lead to FCA Enforcement Policy Changes?
Cruising Through Change: The Auto-Finance Industry’s New Era Under Trump Unveiled — Moving the Metal: The Auto Finance Podcast
Compliance into the Weeds: Changes in FCPA Enforcement
Enforcement Priorities of the Second Trump Administration: The False Claims Act
Daily Compliance News: June 9, 2025, The Repugnant Edition
Foreign Correspondent Podcast | The America First Investment Policy and What it Means for Investors
Hot Topics in International Trade - Tariff Mitigation Strategies
Daily Compliance News: May 29, 2025, The 0 – 3 Edition
Daily Compliance News: May 28, 2025, The Moron Premium Edition
Everything Compliance: Episode 154, The Law Firms in Trouble Edition
Daily Compliance News: May 22, 2025, The Trump and Dump Edition
Compliance into the Weeds: Of Wal-Mart, Tariffs and Stakeholder Capitalism
Everything Compliance: Shout Outs and Rants - Episode 154
Episode 369 -- Stepping Into the Enforcement Spotlight -- Customs and Border Patrol and Import Enforcement
Daily Compliance News: May 16, 2025, The Ethics Nightmare Edition
Navigating Contractor vs. Employee Classification
Compliance into the Weeds: Leaving on a (Qatari) Jet Plane
Daily Compliance News: May 12, 2025, The Corruption in the Broad Daylight Edition
The Federal Trade Commission (FTC) and the Antitrust Division of the U.S. Department of Justice (DOJ), along with the U.S. Department of Commerce and the U.S. Department of Health and Human Services (collectively, “the...more
President Trump’s highly publicized executive order 14297, titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” targets the discrepancy in drug pricing in the United States compared with...more
This order makes it the policy of the United States to have the most-favored-nation price for prescription drugs and biologics. The order directs the Secretary of Commerce and the United States Trade Representative to take...more
Based on recent policy signals and statements from incoming administration officials, a picture of potential regulatory and policy changes that could affect biotech, pharmaceutical, and medical device companies in coming...more
Republicans have swept the 2024 elections, returning Donald Trump to the White House as the 47th President and flipping the Senate to a Republican majority. Having narrowly maintained control of the House of Representatives,...more
A mounting death toll (over 106 and counting) and fears of a coronavirus pandemic sent markets tumbling early on Monday and kicked off a selloff that continued all day....more
On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more